
Emergency Use Authorization for COVID-19 antibody
The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy
The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy
The coronavirus disease 2019 (COVID-19) pandemic has placed the scientific and research communities under extraordinary pressure, to which they have responded with exceptional vigor and speed.
As things rapidly develop on both what we know about COVID-19, policies around telehealth have also been developing alongside of it.
Coronavirus (COVID-19) : History, Update & Action Plan from Dr. Robert Jackson
Dr. Kevin Latinis, M.D. PhD gives an update on his plans for dealing with the Coronavirus (COVID-19) and his patients.
The Danolyte Global Company in Midwestern United States, Overland Park, Kansas has the hypochlorous acid technology that can slow this pandemic down.
Coronavirus disease 2019 (COVID-19) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.